
A study in Communications Medicine suggests the BCG tuberculosis vaccine may retrain innate immune cells in the brain to help clear amyloid-beta plaques associated with Alzheimer’s.
Researchers at Massachusetts General Hospital observed that in participants without established Alzheimer’s, the vaccine appeared to facilitate the movement of amyloid from the brain into the blood.
The study involved 23 older adults who received two BCG doses, though researchers noted the treatment showed limited efficacy in patients with already established dementia.